Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved
M Arenas, S Sabater, V Hernández, A Rovirosa, P C Lara, A Biete, J Panés, M Arenas, S Sabater, V Hernández, A Rovirosa, P C Lara, A Biete, J Panés
Abstract
Low-dose radiotherapy (LD-RT) has been used for several benign diseases, including arthrodegenerative and inflammatory pathologies. Despite its effectiveness in clinical practice, little is known about the mechanisms through which LD-RT modulates the various phases of the inflammatory response and about the optimal dose fractionation. The objective of this review is to deepen knowledge about the most effective LD-RT treatment schedule and radiobiological mechanisms underlying the anti-inflammatory effects of LD-RT in various in vitro experiments, in vivo studies, and clinical studies.
References
- J Immunol. 1946 May;53:95-100
- Strahlenther Onkol. 2003 Nov;179(11):774-8
- Semin Radiat Oncol. 1999 Apr;9(2):163-70
- Gastroenterology. 1998 May;114(5):1066-90
- Strahlenther Onkol. 1998 May;174(5):243-50
- Strahlenther Onkol. 2010 Jan;186(1):24-29
- Berl Munch Tierarztl Wochenschr. 1986 May 1;99(5):148-52
- Radiat Res. 2000 Aug;154(2):178-86
- Strahlenther Onkol. 1999 Nov;175(11):541-7
- J Environ Radioact. 2004;74(1-3):107-16
- Strahlenther Onkol. 2002 Jan;178(1):1-9
- Acta Oncol. 2007;46(2):239-46
- Strahlenther Onkol. 1998 Dec;174(12):633-9
- Strahlenther Onkol. 2011 Sep;187(9):568-74
- Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):828-43
- Risk Anal. 1995 Dec;15(6):645-53
- Int J Radiat Biol. 2005 Sep;81(9):657-67
- Int J Radiat Biol. 2002 Apr;78(4):315-25
- Orthopade. 2004 Jan;33(1):56-62
- Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):560-7
- Health Phys. 1987 May;52(5):521-5
- Int J Radiat Biol. 2003 Dec;79(12):993-1001
- Int Arch Occup Environ Health. 1994;66(2):71-5
- Health Phys. 2002 Jan;82(1):87-93
- Cancer. 2002 Feb 15;94(4 Suppl):1210-4
- Int J Radiat Biol. 2002 Aug;78(8):711-9
- BMJ. 1995 Mar 25;310(6982):801
- Radiologe. 1970 Feb;10(2):51-4
- Radiat Environ Biophys. 2006 Mar;44(4):253-6
- Environ Health Perspect. 1998 Feb;106 Suppl 1:277-83
- Strahlenther Onkol. 2010 Jan;186(1):7-17
- Radiat Res. 2007 Apr;167(4):396-416
- Radiother Oncol. 2004 Apr;71(1):1-2
- Strahlenther Onkol. 2004 Apr;180(4):194-200
- N Engl J Med. 1959 Jan 29;260(5):197-202
- Radiother Oncol. 2008 Mar;86(3):399-406
- Strahlenther Onkol. 2003 Mar;179(3):158-66
- Radiother Oncol. 2010 Nov;97(2):346-51
- Strahlenther Onkol. 2004 Mar;180(3):165-72
- Radiat Res. 1997 Jan;147(1):41-7
- Radiat Res. 1996 Jun;145(6):694-707
- J Radiol Prot. 2006 Sep;26(3):317-24
- Radiother Oncol. 2005 Jan;74(1):3-9
- Strahlenther Onkol. 1995 Sep;171(9):534-8
- Autoimmunity. 2009 May;42(4):343-5
- BMJ. 2005 Jul 9;331(7508):77
- Radiother Oncol. 2000 Mar;54(3):273-82
- Strahlenther Onkol. 1995 Jul;171(7):379-84
- Health Phys. 1987 May;52(5):653-7
- Strahlenther Onkol. 1994 Jan;170(1):1-12
- Radiat Res. 1994 Jun;138(3):367-72
- Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):317-9
- Strahlenther Onkol. 1998 Nov;174(11):580-8
- Strahlenther Onkol. 2010 Feb;186(2):82-90
- Int J Radiat Biol. 1997 Apr;71(4):429-33
- Autoimmunity. 2009 May;42(4):340-2
- Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):161-71
- Int J Radiat Biol. 1999 Aug;75(8):995-1003
- Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):496-513
- Int J Radiat Biol. 2002 Jul;78(7):567-76
- Strahlenther Onkol. 2010 Jan;186(1):18-23
- Semin Radiat Oncol. 1999 Apr;9(2):134-43
- Br Med J. 1965 Dec 4;2(5474):1327-32
- Strahlenther Onkol. 2004 Nov;180(11):718-30
- Strahlenther Onkol. 2008 Jan;184(1):41-7
- Radiother Oncol. 2007 May;83(2):175-7
Source: PubMed